ABSTRACT The pharmacokinetic characteristics of amiodarone suggest extensive tissue deposition. We confirmed this by measuring tissue concentrations of the drug and of its major metabolite, desethylamiodarone, in human tissues. These were obtained at autopsy (n = 9), surgery (n = 7), or biopsy (n = 2) from 18 patients who had been treated with amiodarone for varying periods of time. (89 and 470). and lymph node (83 and 316). We also found high concentrations of amiodarone (306 mg/kg wet weight) and desethylamiodarone (943 mg/kg wet weight) in abnormally pigmented ("blue") skin from patients with amiodarone-induced skin pigmentation. These values were 10-fold higher than those in unpigmented skin from the same patients. These high concentrations were associated with lysosomal inclusion bodies in dermal macrophages in the pigmented skin. The inclusion bodies were intrinsically electron dense and were shown to contain iodine by energy dispersive xray microanalysis. Lysosomal inclusion bodies shown by electron microscopy to be multilamellar were seen in other tissues. These tissues included terminal nerve fibers in pigmented skin, pulmonary macrophages. blood neutrophils. and hepatocytes and Kupffer cells. These characteristic ultrastructural findings occur in both genetic lipidoses and lipidoses induced by other drugs, e.g., perhexiline. We conclude that during therapy with aniodarone, widespread deposition of amiodarone and desethylamiodarone occurs. This leads to ultrastructural changes typical of a lipidosis. These changes are seen clearly in tissues associated with the unwanted effects of amiodarone, e.g., skin, liver and lung. Circulation 72, No. 5, 1064-1075 , 1985 AMIODARONE is recognized as an orally effective agent in the treatment of atrial and ventricular arrhythmias refractory to conventional therapy. It is a benzofuran derivative containing two iodine atoms per molecule. In man, only one major metabolite has been identified, desethylamiodarone.' During long-term therapy this compound reaches similar plasma concentrations to amiodarone, and both compounds show long terminal elimination half-lives reflecting a com-
disorders have been recognized,161" including fatal hepatitis. 14 We have investigated the tissue distribution of amiodarone and desethylamiodarone in man and have noted -ultrastructural changes in various organs during therapy with amiodarone. These observations throw light on the association between the drug's unwanted effects and the accumulation of amiodarone and its desethyl metabolite in the body.
Methods
Study population. The clinical details of the 18 patients from whom tissue samples were obtained are shown in table 1. There were 12 men and six women (mean age + SD 59 +-16 years, see table 1 ). The duration of treatment with amiodarone ranged from 11 days to 53 months and the total cumulative dose varied from 9 to 810 g. Daily dose varied both within and between patients, but the range for long-term dosing was 200 to 800 mg/day. Patients 2, 4, 12, and 13 had received no amiodarone for 3 to 41 days before tissue was obtained. The patients had received a median of six (range 0 to 1 1) other drugs in the 2 years before sampling. Amiodarone was the only drug taken by all patients.
Tissue samples. In nine patients, samples were obtained at autopsy 1 to 4 days after death. In seven patients, biopsy specimens were obtained during surgery (thoracotomy in four and laparotomy in three). All samples were taken during routine surgery or were part of clinically necessary biopsies. In two patients (17 and 18) with amiodarone-induced skin pigmentation, elliptic skin specimens were obtained from affected skin of either the face or the dorsum of the hand.
Unaffected skin was obtained from the trunk or upper arm in the same patients. Similar samples were also obtained from one patient at autopsy (No. 9). In patient 5, pulmonary macrophages were examined after bronchoalveolar lavage and a small lung specimen for histologic examination was also obtained during bronchoscopy. In biopsy samples the mean (+ SEM) concentrations of amiodarone and desethylamiodarone were 1.3 ±-0.5 and 1.6 + 0.6 mg/liter, respectively. For autopsy samples the results were 1.9 -H 1.0 and 3.0 + 0.3 mg/liter, respectively. In the autopsy samples the lysing process probably contributed to the lower ratio of amiodarone to desethylamiodarone concentrations because of the higher concentrations of the latter compound in red cells than in plasma.19 In addition, postmortem changes in blood concentrations depending on the sampling site cannot be ruled out'0 High concentrations of amiodarone and desethylamiodarone were found in tissue (tables 2 and 3); the highest concentrations were found in liver, with mean concentrations (amiodarone/desethylamiodarone, mg/ kg wet weight) of 659/3335 in biopsy specimens (n = 3) and 391/2354 in autopsy samples (n = 9). The range of concentrations of amiodarone and of desethylamiodarone in a particular tissue was wide, reflecting differences in dose and duration of therapy and the time since therapy had been discontinued (patients 2, 4, 12, and 13). However, the concentrations of both of the compounds were consistently highest in liver, lung, adrenal gland, testis, spleen, and lymph node Vol. 72, No. 5, November 1985 and were lowest in skeletal muscle, thyroid gland, skin, and brain. This pattern was seen in all of the patients.
The ratio of amiodarone to desethylamiodarone concentrations was lower in tissues than in plasma (table  4) , ranging from 0. 13 to 0.72. In fat, however, the ratio of amiodarone to desethylamiodarone was 4.67. Mean concentrations in fat were as follows: biopsy specimens, amiodarone 344 mg/kg wet weight, desethylamiodarone 80.5 mg/kg; autopsy specimens, amiodarone 316 mg/kg wet weight, desethylamiodarone 76.5 mg/kg. Dru(g ancd mnetabolite conicentrations in pigmnented and unpigmenited skin. Concentrations of amiodarone and desethylamiodarone were compared in normal and pigmented skin from the three patients with amiodarone-induced cutaneous pigmentation (Nos. 5, 17, and 18) (table 5) . In all three patients the concentrations of both compounds were much higher in pigmented than in unpigmented skin. Histology Skini. In skin affected by amiodarone-induced cutaneous pigmentation there was a striking accumulation of dermal macrophages with a perivascular localiza- Figure 1 shows that many of the bodies appeared electron dense and relatively homogeneous but that some (at higher magnification) were multilamellar with a single limiting membrane. Similar dense bodies and occasional multilamellar inclusions were seen in terminal nerve fibers and infrequently in vascular endothelial cells.
Energy-dispersive x-ray microanalysis was performed on sections from the same blocks. In figure 2 a typical energy spectrum obtained from an electrondense granule (top) in pigmented skin is contrasted with that from background cytoplasm (bottom) in the dermal macrophages. There was a high concentration of iodine and phosphorus in the electron-dense granule, the high phosphorus content probably reflecting phospholipid accumulation. The high iodine concentration was consistent with local accumulation of amiodarone or desethylamiodarone or other iodinecontaining metabolites. Even without exposure to heavy metal during processing and when unstained, the granules appeared electron dense during routine transmission electron microscopy, further supporting the presence of an element with high atomic number, presumably iodine. The patient from whom the sample for energy-dispersive microanalysis was taken had never received iodine-containing contrast media.
Lun?g. Light microscopy of lung sections was performed in patients 8, 9, 10, 12. 15, and 16 (autopsy samples) and in patient 5 (transbronchial biopsy, araldite-embedded specimens only). In patient 5, amiodarone pulmonary toxicity was suspected because of a reduced carbon monoxide diffusion capacity, associat- ed with apical shadowing on the chest radiograph. In patient 12, large numbers and in patients 8 and 9 moderate numbers of intra-alveolar foamy macrophages were present. In patients 10, 15, and 16 similar cells were absent or sparse. In the araldite-embedded specimens from patients 5 toluidine blue staining showed the macrophages to be full of densely staining granules.
Electron microscopy was performed in lung specimens from patient 5 ( figure 3 ). The granules seen by light microscopy in pulmonary macrophages were revealed to be multilamellar inclusions similar to those seen in some dermal macrophages and in terminal nerve fibers in pigmented skin. Macrophages in bronchoalveolar lavage specimens were of identical appearance. Energy-dispersive x-ray microanalysis showed that the multilamellar bodies in macrophages obtained by lavage contained considerable quantities of iodine. The patient had had an intravenous urogram 1 year before biopsy and we cannot exclude a contribution of iodine from the contrast medium used at that time.
Peripheral neutrophils. Electron microscopy of neutrophils was possible in patients 5 and 17. In patient 5 , between five and 10 multilamellar bodies with a single limiting membrane were seen in each cell profile (figure 4). These were very similar to those seen in other tissues. In patient 17 somewhat abnormal lysosomal bodies were seen but they did not have similar multilamellar contents.
Liver. In patient 9, liver biopsy was performed because of evidence of hepatitis with a low plasma albumin concentration. Light microscopy revealed preservation of normal lobular architecture with a mild inflammatory infiltrate, predominantly lymphocytic. Many hepatocytes were swollen with large lipid vacuoles. Kupffer cells were prominent with diastaseresistant, periodic acid-Schiff positive granules. Electron microscopy (figure 5) revealed that the vacuoles in hepatocytes and granules in Kupffer cells represented multilamellar bodies, similar in appearance to those seen in skin, neutrophils, and lung. Similar but less marked changes were seen in patient 5, in whom aspartate transaminase concentrations were persistently elevated to twice normal. Similar changes were also seen in patient 7, but interpretation was complicated by the presence of a lymphoma. In patient 12, changes of long-standing cardiac failure were the only abnormalities seen. In this case the aspartate transaminase concentrations were normal.
Energy dispersive x-ray analysis by the same technique as before consistently failed to reveal iodine in give any clue about the mechanism responsible for this distribution? The high concentrations of amiodarone in fat are consistent with its lipid solubility, but desethylning the tisamiodarone is also highly lipid soluble. The high conhylamiodacentrations of both compounds in liver, lung, adrenal ,olated case gland, and testis would in themselves be consistent
.23 Yet for a with the lipid solubility of these compounds. Howevf-life of 53 er, the disproportionately high concentrations of deof several sethylamiodarone in these tissues (table 4) suggest the likely to be possibility of another mechanism. The observation of v extensive high amiodarone and desethylamiodarone concentrabrief intrations in pigmented skin in association with large num- bers of macrophages laden with secondary lysosomes suggested that the tissue distribution could be related to varying uptake of drug and metabolite by macrophages. Liver, lung, spleen, adrenal gland, and testis all contain large numbers of macrophages or other cells that actively take up lipid or lipid-rich membrane fragments into lysosomes; we have shown that all these tissues accumulate amiodarone and desethylamiodarone in large amounts.
Ultrastructure and drug and metabolite concentrations.
The ultrastructural changes seen in skin, i.e., iodinecontaining, lipid-rich inclusions within macrophages, were associated with high concentrations of amiodarone and desethylamiodarone. Similar inclusions were seen in pulmonary macrophages, Kupffer cells, hepatocytes, and peripheral neutrophils. Electron microscopic and histochemical analysis of these bodies suggested they were of lysosomal origin. Our results are consistent with the inclusion bodies containing amiodarone and desethylamiodarone. Evidence for this comes from the electron density of inclusions in skin sections observed in electron microscopy, even without heavy metal stains; high local concentrations of an electron-dense element, such as iodine, would produce this appearance. Furthermore, the en- bodies being less prominent in the skin, some were clearly multilamellar ( figure 1, A) . Slight variations in binding may explain these differences.
In our patients ultrastructural changes were associated most strongly with a clinically recognized unwanted effect. Other authors have recognized this association. The corneal deposits that develop in almost all patients receiving long-term amiodarone therapy are caused by multilamellar inclusions in corneal and conjunctival epithelial tissue2t and are associated with high iodine concentrations.29 Similar multilamellar bodies have been recognized in pulmonary macrophages, type II pneumocytes, and vascular endothelial cells in patients with pulmonary toxicity ascribed to amiodarone. Ill 12 We have confirmed these findings in patient 5 of this series and in other patients.30 Multilamellar hepatic inclusions have also been seen by other authors. 14, 16. 17 Similar inclusions have been seen in peripheral nerve in patients with amiodarone-associated neuropathy. 31 Thus inclusions are seen in association with amiodarone-related adverse effects in some patients and probably in the corneal epithelium of most patients taking the drug. These findings, together with our data on tissue concentrations, again indicate that widespread 1072 tissue deposition of amiodarone and desethylamiodarone leads to ultrastructural changes in many sites. These changes, some of which are associated with adverse reactions to amiodarone, are of the type seen in lipid storage disorders, both drug induced and genetically determined.
Other drugs produce such ultrastructural changes in animals and in man."2 The association of drug accumulation in body tissues with lipid-rich lamellar or crystalloid cytoplasmic inclusions in a variety of cell types suggests the development of a drug-induced lipid storage disorder.
Several drugs have been implicated in the production of a lipidosis in man. Chloroquine produces a corneal dystrophy with gross and ultrastructural features similar to those produced by amiodarone,79 and in a patient with chloroquine-associated myopathy, multilamellar inclusions were found in muscle. produced frequent "phospholipid fatty liver"37 characterized by abnormal lipid metabolism and frequent multilamellar bodies in Kupffer cells and in hepatocytes. These changes were also seen in other tissues. 38 These common morphologic changes are paralleled by a tendency for all these compounds to accumulate in AMIODARONE Fat tissues. 4,4'-DH can be found in tissue 18 months after the drug is discontinued, whereas the half-life of perhexiline in patients with neuropathy ranges between 9 and 22 days. 39 Similar morphologic changes to those described with amiodarone and other drugs occur during the de- 
